by Jason Heaviland | Oct 29, 2025
Explore Panome Bio’s in-depth proteomics data report profiling global protein expression changes in HCT-116 cells with KRAS knockout. This analysis highlights key signaling pathways and molecular alterations revealed through advanced discovery proteomics analysis,...
by ODWAdmin | Sep 26, 2025 | Uncategorized
Proteolysis targeting chimeras (PROTACs) represent a revolutionary approach to targeted protein degradation, offering unprecedented opportunities to modulate previously “undruggable” targets in cancer and other diseases. As PROTAC research progresses from...
by Jason Heaviland | Sep 8, 2025 | Uncategorized
Phenotypic Screening and Target Deconvolution for Molecular Glue Discovery Molecular glue degraders represent a unique class of therapeutic compounds that modify E3 ligase substrate specificity to induce targeted protein degradation. Unlike PROTACs, which require...
by Jason Heaviland | Sep 8, 2025 | Uncategorized
The Assumption That Derails Programs The promise of mRNA therapeutics is elegant: deliver genetic instructions, let cells produce therapeutic proteins, and bypass traditional drug manufacturing. But there’s a critical gap between mRNA design and therapeutic...
by ODWAdmin | Nov 21, 2024
Discover unique proteomic insights in this sample data report that includes an analysis of colorectal cancer patients compared to healthy adults with the Seer Proteograph XT + Orbitrap Astral mass...
